全部 标题 作者
关键词 摘要

OALib Journal期刊
ISSN: 2333-9721
费用:99美元

查看量下载量

相关文章

更多...

69例肾盂和输尿管癌术后发生膀胱肿瘤的相关因素分析

, PP. 716-718

Keywords: 肾盂癌,输尿管癌,膀胱肿瘤,随访

Full-Text   Cite this paper   Add to My Lib

Abstract:

目的探讨肾盂、输尿管癌患者术后发生膀胱肿瘤的相关因素。方法对宁夏医科大学总医院泌尿外科69例肾盂、输尿管癌,随访6个月~5年,记录患者术后膀胱肿瘤发生情况,分析性别、肿瘤部位、肿瘤大小、病理分期、组织分级、手术方式、术后是否膀胱灌注等与术后发生膀胱肿瘤的关系。结果69例中,随访期内发生膀胱肿瘤16例,复发率为23.2%。患者的肿瘤大小、肿瘤分期、术后是否灌注与肾盂、输尿管癌术后发生膀胱肿瘤有关(P<0.05)。结论肿瘤大小、病理分期、术后是否灌注是影响肾盂、输尿管癌患者术后发生膀胱肿瘤的相关因素。

References

[1]  吴阶平.吴阶平泌尿外科学[M].济南:山东科学技术出版社,2004:961-965.
[2]  Hisataki T,Miyao N,Masumori N,et al.Risk factors for the development of bladder cancer after upper tract urothelial cancer[J].Urology,2000,55:663-667.
[3]  Matsui Y,Utsunomiya N,Ichioka K,et al.Risk factors for subsequent development of bladder cancer after primary transitional cell carcinoma of the upper urinary tract[J].Urology,2005,65:279-283.
[4]  孔垂泽,刘奔,李振华,等.预防肾盂输尿管癌术后再发膀胱癌的手术方法研究[J].中华泌尿外科杂志,2006,27:250-252.
[5]  Tsunenori K,Shiro O,Osamu R, et al. Analysis of prognostic factors related to primary superficial bladder cancer tumor recurrence in prophylactic intravesical epirubicin therapy[J].Internation Journal of Urology,1999,6:178-183.
[6]  Hall MC,Womack S,Sagaloeskyv AI,et al.Prognostic factors, recurrence, and survival in transitional cell carcinoma of the upper urinary tract:a 30-year experience in 252 patients[J].Urology,1998,52:594-601.
[7]  Simon V.Bariol,Grant D.Stewart,et al.Oncological control following laparoscopic nephroureterectomy:7-year outcome[J].The Journal of Urology,2004, 172:1805-1808.
[8]  Sakamoto N,Naito S,Kumazawa J,et al.Prophylactic intravesical instillation of mitomycin C and cytosine arabinoside for prevention of recurrent bladder tumors following surgery for upper urinary tract tumors:a prospective randomized study[J].International Journal of Urology,2001,8:212-216.

Full-Text

Contact Us

service@oalib.com

QQ:3279437679

WhatsApp +8615387084133